The Sphingolipid-Modulating Drug Opaganib Protects against Radiation-Induced Lung Inflammation and Fibrosis: Potential Uses as a Medical Countermeasure and in Cancer Radiotherapy.

Autor: Maines, Lynn W.1 (AUTHOR), Keller, Staci N.1 (AUTHOR), Smith, Ryan A.1 (AUTHOR), Green, Cecelia L.1 (AUTHOR), Smith, Charles D.1 (AUTHOR) cdsmith@apogee-biotech.com
Zdroj: International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 4, p2322. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje